Amoxicillin-treated green-synthesized iron oxide nanoparticles from Artemisia absinthium L.: UV-vis behaviour over 26 weeks, antioxidant activity and preliminary MCF-7 cytotoxicity

Authors: Abdussalam-Mohammed, Wanisa; Younes, Adel; Al-Masri, Walaa; Alshaikh, Mashael M; Khlifa, Moussa; Bhattarai, Ajaya

Source journal: RSC advances (2026-11-18)

DOI: 10.1039/d6ra08534b

Abstract

Green synthesis of iron oxide nanoparticles (IONPs) with prolonged dispersion stability remains a challenge for biomedical applications. Here, IONPs were synthesized using Libyan wormwood (Artemisia absinthium L.) leaf extract and combined with amoxicillin at pH 8 to obtain IONPs-Amoxi. Notably, the unbound drug fraction was not quantified, and the corresponding supernatants were not retained. Transmission electron microscopy (TEM) revealed an average core diameter of 39.5 +/- 24 nm, while dynamic light scattering (DLS) indicated a hydrodynamic diameter of 47 +/- 3.5 nm. Fourier-transform infrared spectroscopy (FTIR) showed spectral features consistent with interactions between amoxicillin functional groups and the nanoparticle surface. The zeta potential was -83.97 mV. During 26 weeks of storage under ambient conditions, no visible precipitation was observed, although UV-vis absorption intensity decreased over time, indicating a degree of optical aging. In preliminary antioxidant testing, IONPs-Amoxi exhibited concentration-dependent DPPH radical-scavenging activity, reaching 92.6% inhibition at 500 microg mL(-1), compared with 99.3% for ascorbic acid. In an MTT assay against MCF-7 breast cancer cells, the formulation produced 88.28% cytotoxicity at 25 microg mL(-1), with a reported IC(50) of approximately 3.66 microg mL(-1). These findings suggest the feasibility of plant-mediated IONP fabrication and indicate promising preliminary antioxidant and in vitro cytotoxic profiles. Further studies involving matched nanoparticle controls, quantitative drug-association analysis, release kinetics, comprehensive storage characterization, and mechanistic assays are required to fully clarify the contributions of the formulation components.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.